---
document_datetime: 2023-09-21 19:30:37
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/entacapone-orion-epar-all-authorised-presentations_en.pdf
document_name: entacapone-orion-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9128292
conversion_datetime: 2025-12-20 17:58:19.742406
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name    | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging     | Package size   |
|-----------------|------------------|------------|-----------------------|---------------------------|---------------|----------------|
| EU/1/11/708/001 | Entacapone Orion | 200 mg     | Film-coated tablet    | Oral use                  | bottle (HDPE) | 30 tablets     |
| EU/1/11/708/002 | Entacapone Orion | 200 mg     | Film-coated tablet    | Oral use                  | bottle (HDPE) | 60 tablets     |
| EU/1/11/708/003 | Entacapone Orion | 200 mg     | Film-coated tablet    | Oral use                  | bottle (HDPE) | 100 tablets    |
| EU/1/11/708/004 | Entacapone Orion | 200 mg     | Film-coated tablet    | Oral use                  | bottle (HDPE) | 175 tablets    |